What is Doximity's other financing?

Doximity (DOCS) reported other financing of $5.25M in Q2 2025.

How has Doximity's other financing changed year-over-year?

Doximity's other financing decreased by 4.0% year-over-year, from $5.47M to $5.25M.

What does other financing mean?

Miscellaneous financing cash flows not classified in specific line items.

Doximity DOCS Other Financing

Other Financing at other companies

MicrosoftMSFT

-$509M-33.2%

SolventumSOLV

-$31M-288%

BrightSpring Health Services, Inc.BTSG

$50K-88.9%

McKessonMCK

-$63M+71.1%

IQVIAIQV

$4M-33.3%

NovantaNOVT

$4.39M—

Other financials

Income statement

See full

Revenue$145.4M+5.1%

Gross profit$126.0M+1.7%

Operating income$24.8M-49.0%

Net income$19.1M-69.4%

EPS (diluted)$0.10-67.7%

Balance sheet

See full

Cash & equivalents$219.2M+4.6%

Total debt$10.2M-17.8%

Total equity$950.8M-12.2%

Total assets$1.1B-11.1%

Cash flow

See full

Operating cash flow$109.5M+11.2%

CapEx-—

Free cash flow$81.6M-17.1%

Valuation

See full

Market cap$3.75B-60.5%

Profitability

See full

Gross margin89.1%-1.1pp

Operating margin33.3%-6.6pp

Net margin30.4%-8.7pp

FCF margin50.6%+2.7pp

Returns & leverage

See full

Return on equity19.3%-3.2pp

Debt / equity0×0.0×

Current ratio6.1×-0.9×

Where this comes from

Reported directly by Doximity in its filing.

Tagged under the XBRL concept us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities.

The official record: Doximity’s 10-Q, filed August 7, 2025, on SEC EDGAR. View the filing →

Ask your AI about Doximity's other financing.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Doximity's other financing?: Doximity (DOCS) reported other financing of $5.25M in Q2 2025.
How has Doximity's other financing changed year-over-year?: Doximity's other financing decreased by 4.0% year-over-year, from $5.47M to $5.25M.
What does other financing mean?: Miscellaneous financing cash flows not classified in specific line items.